Bellevue Group AG
Reported holdings as of Q2 2026, from 31 quarterly filings.
Holdings
| Security | Ticker | Value | Shares | Weight | Weight change | Held | Change |
|---|---|---|---|---|---|---|---|
| AMGEN INC | AMGN | $308.4M | 851,550 | +4.02pp | 31q | +188.3%+$201.4M | |
| VERTEX PHARMACEUTICALS INC | VRTX | $287.4M | 578,634 | -1.20pp | 31q | -15.1%-$51.3M | |
| ARGENX SE | ARGX | $279.3M | 301,000 | +0.44pp | 31q | -3.8%-$11.1M | |
| GILEAD SCIENCES INC | GILD | $272.7M | 2,158,772 | +1.86pp | 31q | +84.5%+$124.9M | |
| REVOLUTION MEDICINES INC | RVMD | $196.3M | 1,048,014 | +0.56pp | 23q | -32.1%-$93.0M | |
| ORUKA THERAPEUTICS INC | ORKA | $157.7M | 1,657,190 | +2.73pp | 2q | +226.9%+$109.5M | |
| INSMED INC | INSM | $148.6M | 1,393,418 | +3.09pp | 31q | +13787.0%+$147.5M | |
| SCHOLAR ROCK HLDG CORP | SRRK | $134.7M | 2,449,547 | -1.36pp | 29q | -31.7%-$62.4M | |
| NUVALENT INC | NUVL | $130.1M | 1,053,268 | +0.17pp | 3q | HELD | |
| VIRIDIAN THERAPEUTICS INC | VRDN | $123.7M | 6,731,909 | -0.53pp | 3q | HELD | |
| RELAY THERAPEUTICS INC | RLAY | $115.7M | 6,185,970 | +0.59pp | 24q | -20.6%-$30.1M | |
| VAXCYTE INC | PCVX | $114.6M | 1,971,935 | +0.77pp | 2q | +65.6%+$45.4M | |
| UNITED THERAPEUTICS CORP DEL | UTHR | $102.1M | 188,515 | +2.12pp | 4q | +8976.3%+$101.0M | |
| INTUITIVE SURGICAL INC | ISRG | $101.3M | 254,809 | -1.01pp | 31q | -11.1%-$12.7M | |
| REGENERON PHARMACEUTICALS | REGN | $98.1M | 157,291 | -3.06pp | 27q | -43.6%-$75.7M | |
| CRINETICS PHARMACEUTICALS IN | CRNX | $98.0M | 2,620,000 | -0.77pp | 3q | -20.1%-$24.7M | |
| BRIDGEBIO PHARMA INC | BBIO | $88.6M | 1,189,506 | +1.82pp | 14q | +4587.3%+$86.7M | |
| IMMUNOCORE HLDGS PLC | IMCR | $88.5M | 2,788,245 | -0.14pp | 12q | HELD | |
| ABBOTT LABORATORIES | ABT | $85.9M | 947,115 | -1.01pp | 31q | -17.8%-$18.6M | |
| STRYKER CORPORATION | SYK | $84.5M | 268,461 | +0.08pp | 31q | +23.6%+$16.1M | |
| MEDTRONIC PLC | MDT | $77.8M | 994,233 | -0.34pp | 31q | +3.9%+$2.9M | |
| IONIS PHARMACEUTICALS INC | IONS | $77.1M | 972,258 | -1.63pp | 31q | -46.5%-$67.1M | |
| ENLIVEN THERAPEUTICS INC | ELVN | $75.6M | 1,490,000 | -0.57pp | 2q | -35.8%-$42.2M | |
| VERA THERAPEUTICS INC | VERA | $73.4M | 1,710,808 | -0.09pp | 3q | HELD | |
| JADE BIOSCIENCES INC | JBIO | $67.9M | 3,057,996 | +0.26pp | 3q | -12.7%-$9.9M | |
| EDWARDS LIFESCIENCES CORP | EW | $66.9M | 739,234 | -0.19pp | 31q | -11.9%-$9.1M | |
| ULTRAGENYX PHARMACEUTICAL IN | RARE | $66.2M | 1,982,775 | +0.21pp | 3q | -16.7%-$13.3M | |
| UNITEDHEALTH GROUP INC | UNH | $62.0M | 149,127 | +0.35pp | 31q | +0.6%+$384.0K | |
| DEXCOM INC | DXCM | $55.4M | 822,489 | -0.01pp | 31q | +4.3%+$2.3M | |
| CELLDEX THERAPEUTICS INC NEW | CLDX | $44.7M | 1,200,000 | +0.03pp | 17q | HELD | |
| AVALYN PHARMACEUTICALS INC | AVLN | $44.4M | 1,350,000 | - | new | NEW | |
| DAMORA THERAPEUTICS INC | DMRA | $42.1M | 1,618,846 | -0.53pp | 2q | -29.6%-$17.7M | |
| DISC MEDICINE INC | IRON | $41.0M | 560,000 | +0.16pp | 2q | +21.9%+$7.4M | |
| THERMO FISHER SCIENTIFIC INC | TMO | $40.0M | 79,816 | +0.09pp | 31q | +23.9%+$7.7M | |
| BOSTON SCIENTIFIC CORP | BSX | $37.9M | 887,650 | -1.39pp | 31q | -39.5%-$24.7M | |
| ELI LILLY & CO | LLY | $35.8M | 29,882 | +0.01pp | 17q | -11.9%-$4.9M | |
| CG ONCOLOGY INC | CGON | $35.1M | 493,596 | - | new | NEW | |
| IDEXX LABS INC | IDXX | $32.5M | 61,780 | -0.51pp | 31q | -30.7%-$14.4M | |
| RESMED INC | RMD | $28.9M | 148,195 | -0.24pp | 31q | -7.0%-$2.2M | |
| KRYSTAL BIOTECH INC | KRYS | $28.8M | 77,530 | -2.36pp | 19q | -83.9%-$150.2M | |
| MONTE ROSA THERAPEUTICS INC | GLUE | $28.8M | 1,190,000 | +0.12pp | 2q | -4.8%-$1.5M | |
| DANAHER CORP DEL | DHR | $27.4M | 143,844 | -0.34pp | 31q | -28.8%-$11.1M | |
| JOHNSON & JOHNSON | JNJ | $26.2M | 103,280 | -0.14pp | 23q | -13.3%-$4.0M | |
| SEAPORT THERAPEUTICS INC | SPTX | $23.9M | 1,100,000 | - | new | NEW | |
| PALVELLA THERAPEUTICS INC NE | PVLA | $23.7M | 155,000 | - | new | NEW | |
| ALIGN TECHNOLOGY INC | ALGN | $23.6M | 139,680 | -0.07pp | 31q | HELD | |
| ANNEXON INC | ANNX | $23.4M | 4,100,016 | -0.19pp | 10q | -20.5%-$6.0M | |
| HUMANA INC | HUM | $23.2M | 58,398 | +0.22pp | 31q | -9.5%-$2.4M | |
| ELEVANCE HEALTH INC FORMERLY | ELV | $21.8M | 56,449 | +0.09pp | 31q | +7.5%+$1.5M | |
| TANGO THERAPEUTICS INC | TNGX | $21.7M | 694,182 | -0.74pp | 3q | -71.1%-$53.3M | |
| STERIS PLC | STE | $21.0M | 99,877 | -0.08pp | 10q | HELD | |
| SPYRE THERAPEUTICS INC | SYRE | $20.4M | 229,931 | - | new | NEW | |
| HEMAB THERAPEUTICS HLDGS INC | $20.2M | 550,000 | - | new | NEW | ||
| INSULET CORP | PODD | $19.4M | 127,498 | -0.41pp | 31q | -22.1%-$5.5M | |
| THE CIGNA GROUP | CI | $18.3M | 66,500 | -0.24pp | 30q | -32.3%-$8.8M | |
| GLAUKOS CORP | GKOS | $18.0M | 128,667 | +0.01pp | 10q | -11.7%-$2.4M | |
| CVS HEALTH CORP | CVS | $17.5M | 169,366 | +0.22pp | 31q | +89.5%+$8.3M | |
| BECTON DICKINSON & CO | BDX | $16.6M | 109,729 | -0.11pp | 31q | -10.0%-$1.8M | |
| GE HEALTHCARE TECHNOLOGIES I | GEHC | $16.2M | 252,744 | -0.37pp | 12q | -39.4%-$10.5M | |
| LIVANOVA PLC | LIVN | $16.1M | 195,621 | +0.06pp | 2q | +5.1%+$775.9K | |
| CENTENE CORP DEL | CNC | $14.7M | 228,865 | +0.11pp | 31q | -12.3%-$2.1M | |
| MERCK & CO INC | MRK | $14.5M | 113,061 | -0.29pp | 17q | -45.3%-$12.0M | |
| COOPER COS INC | COO | $14.1M | 197,135 | -0.17pp | 10q | -27.6%-$5.4M | |
| PARABILIS MEDICINES INC | PBLS | $13.7M | 500,000 | - | new | NEW | |
| TEVA PHARMACEUTICAL INDS LTD | TEVA | $11.7M | 345,899 | +0.07pp | 10q | +38.3%+$3.2M | |
| GLOBUS MED INC | GMED | $11.5M | 146,108 | -0.26pp | 31q | -40.9%-$8.0M | |
| PROCEPT BIOROBOTICS CORP | PRCT | $11.3M | 502,286 | -0.06pp | 20q | HELD | |
| ZIMMER BIOMET HOLDINGS INC | ZBH | $10.9M | 126,707 | -0.11pp | 31q | -18.6%-$2.5M | |
| VEEVA SYS INC | VEEV | $10.5M | 59,347 | -0.01pp | 31q | +5.0%+$502.2K | |
| ABBVIE INC | ABBV | $10.2M | 40,476 | -0.27pp | 27q | -56.7%-$13.4M | |
| 10X GENOMICS INC | TXG | $10.0M | 261,470 | +0.04pp | 28q | -20.6%-$2.6M | |
| HCA HEALTHCARE INC | HCA | $9.3M | 23,750 | -0.23pp | 31q | -37.1%-$5.5M | |
| AURA BIOSCIENCES INC | AURA | $8.3M | 1,166,667 | - | new | NEW | |
| MCKESSON CORP | MCK | $7.3M | 9,625 | -0.31pp | 31q | -56.9%-$9.6M | |
| TENET HEALTHCARE CORP | THC | $7.3M | 38,868 | -0.02pp | 4q | +1.6%+$112.1K | |
| PROTAGONIST THERAPEUTICS INC | PTGX | $6.8M | 55,682 | +0.11pp | 12q | +285.4%+$5.1M | |
| NATERA INC | NTRA | $6.7M | 24,806 | -0.01pp | 15q | -21.7%-$1.9M | |
| TRANSMEDICS GROUP INC | TMDX | $6.7M | 101,139 | -0.10pp | 25q | HELD | |
| MOLINA HEALTHCARE INC | MOH | $6.3M | 27,761 | - | new | NEW | |
| ALKERMES PLC | ALKS | $6.3M | 120,243 | +0.13pp | 4q | +1255.6%+$5.8M | |
| ROYALTY PHARMA PLC | RPRX | $6.3M | 112,311 | +0.09pp | 4q | +193.3%+$4.2M | |
| WAYSTAR HLDG CORP | WAY | $6.0M | 293,592 | -0.02pp | 9q | +14.6%+$768.9K | |
| PRIVIA HEALTH GROUP INC | PRVA | $5.8M | 226,703 | +0.01pp | 21q | HELD | |
| GMR SOLUTIONS INC | GMRS | $5.2M | 333,333 | - | new | NEW | |
| NEUROCRINE BIOSCIENCES INC | NBIX | $4.1M | 24,037 | +0.07pp | 31q | +417.4%+$3.3M | |
| OMADA HEALTH INC | OMDA | $3.5M | 157,938 | +0.03pp | 5q | HELD | |
| KESTRA MED TECHNOLOGIES LTD | KMTS | $3.3M | 129,215 | +0.01pp | 6q | +11.8%+$346.6K | |
| MEDLINE INC | MDLN | $3.2M | 82,153 | -0.08pp | 3q | -39.9%-$2.1M | |
| ILLUMINA INC | ILMN | $3.2M | 18,134 | +0.01pp | 31q | -10.3%-$367.3K | |
| BEONE MEDICINES LTD | ONC | $3.0M | 10,474 | +0.04pp | 16q | +174.8%+$1.9M | |
| NEWAMSTERDAM PHARMA COMPANY | NAMS | $2.9M | 86,994 | +0.04pp | 8q | +214.5%+$2.0M | |
| MADRIGAL PHARMACEUTICALS INC | MDGL | $2.5M | 4,675 | +0.01pp | 10q | +53.8%+$877.9K | |
| STATE STR SPDR S&P 500 ETF T | SPY | $2.0M | 2,700 | flat | 7q | HELD | |
| BIONTECH SE | BNTX | $2.0M | 21,229 | flat | 8q | +1.8%+$35.2K | |
| ADAPTIVE BIOTECHNOLOGIES COR | ADPT | $1.9M | 89,439 | +0.02pp | 4q | +17.4%+$284.4K | |
| CYTOKINETICS INC | CYTK | $1.6M | 19,007 | +0.02pp | 18q | +115.0%+$866.0K | |
| ALAMAR BIOSCIENCES INC | ALMR | $1.5M | 55,738 | - | new | NEW | |
| PHREESIA INC | PHR | $1.4M | 140,495 | flat | 28q | +7.3%+$97.8K | |
| MOBIA MED INC | $1.3M | 100,000 | - | new | NEW | ||
| BILLIONTOONE INC | BLLN | $1.3M | 10,554 | +0.01pp | 3q | HELD | |
| BETA BIONICS INC | BBNX | $1.1M | 72,152 | +0.01pp | 6q | HELD | |
| LEGEND BIOTECH CORP | LEGN | $954.6K | 33,054 | flat | 23q | -7.9%-$81.8K | |
| PFIZER INC | PFE | $925.4K | 38,431 | -0.05pp | 12q | -64.3%-$1.7M | |
| ABIVAX SA | ABVX | $852.5K | 6,397 | +0.02pp | 2q | +510.4%+$712.8K | |
| ENCOMPASS HEALTH CORP | EHC | $702.6K | 6,951 | -0.01pp | 11q | -29.3%-$290.9K | |
| AXSOME THERAPEUTICS INC | AXSM | $658.2K | 2,689 | flat | 21q | -15.5%-$120.4K | |
| CERTARA INC | CERT | $651.3K | 99,442 | flat | 12q | HELD | |
| AGOMAB THERAPEUTICS NV | AGMB | $639.2K | 49,248 | flat | 2q | -1.5%-$9.8K | |
| PRAXIS PRECISION MEDICINES I | PRAX | $618.4K | 1,847 | flat | 2q | +5.1%+$30.1K | |
| APPLE INC | AAPL | $540.5K | 1,768 | -0.01pp | 4q | -46.7%-$474.5K | |
| GARMIN LTD | GRMN | $469.4K | 1,976 | flat | 10q | +49.6%+$155.6K | |
| DENALI THERAPEUTICS INC | DNLI | $456.9K | 17,766 | flat | 3q | HELD | |
| VANECK ETF TRUST | GDX | $433.8K | 5,750 | flat | 7q | HELD | |
| VERADERMICS INC | MANE | $426.4K | 3,468 | - | new | NEW | |
| ALPHABET INC | GOOGL | $395.6K | 907 | +0.01pp | 6q | +188.9%+$258.7K | |
| DEFINIUM THERAPEUTICS INC | DFTX | $394.7K | 8,391 | - | new | NEW | |
| TRAVERE THERAPEUTICS INC | TVTX | $392.4K | 6,908 | flat | 3q | -22.4%-$113.1K | |
| AMAZON COM INC | AMZN | $382.5K | 1,605 | flat | 6q | +18.6%+$60.1K | |
| HALOZYME THERAPEUTICS INC | HALO | $340.3K | 4,348 | flat | 2q | +12.7%+$38.4K | |
| ALNYLAM PHARMACEUTICALS INC | ALNY | $328.7K | 1,092 | -1.84pp | 31q | -99.5%-$70.3M | |
| CRISPR THERAPEUTICS AG | CRSP | $317.3K | 5,818 | flat | 3q | +16.0%+$43.7K | |
| STRUCTURE THERAPEUTICS INC | GPCR | $255.6K | 4,762 | flat | 12q | -30.0%-$109.5K | |
| VIATRIS INC | VTRS | $250.6K | 15,778 | - | new | NEW | |
| MINERALYS THERAPEUTICS INC | MLYS | $236.2K | 8,753 | -0.01pp | 10q | -70.2%-$556.4K | |
| SUMMIT THERAPEUTICS INC | SMMT | $222.6K | 15,279 | flat | 8q | -3.7%-$8.4K | |
| CARDINAL HEALTH INC | CAH | $202.4K | 852 | flat | 11q | -1.3%-$2.6K | |
| COGENT BIOSCIENCES INC | COGT | $188.5K | 4,870 | - | new | NEW | |
| TEMPUS AI INC | TEM | $186.1K | 3,213 | flat | 9q | -35.1%-$100.6K | |
| CENCORA INC | COR | $163.0K | 576 | -0.01pp | 18q | -66.4%-$322.6K | |
| PTC THERAPEUTICS INC | PTCT | $132.6K | 1,626 | flat | 7q | -16.0%-$25.2K | |
| CARIS LIFE SCIENCES INC | CAI | $114.4K | 6,418 | flat | 5q | HELD | |
| RHYTHM PHARMACEUTICALS INC | RYTM | $112.8K | 1,016 | flat | 12q | HELD | |
| ARROWHEAD PHARMACEUTICALS IN | ARWR | $97.1K | 1,191 | flat | 3q | -22.9%-$28.9K | |
| NVIDIA CORPORATION | NVDA | $81.6K | 408 | flat | 11q | HELD | |
| LABCORP HOLDINGS INC | LH | $78.4K | 280 | flat | 9q | HELD | |
| BIOGEN INC | BIIB | $73.0K | 338 | -0.01pp | 24q | -90.7%-$716.2K | |
| BRISTOL-MYERS SQUIBB CO | BMY | $70.1K | 1,216 | -0.02pp | 8q | -92.9%-$911.7K | |
| WATERS CORP | WAT | $67.1K | 179 | - | new | NEW | |
| MICROSOFT CORP | MSFT | $64.2K | 172 | flat | 11q | HELD | |
| IQVIA HLDGS INC | IQV | $56.6K | 293 | flat | 26q | -60.4%-$86.4K | |
| INCYTE CORP | INCY | $55.1K | 486 | flat | 31q | HELD | |
| METTLER TOLEDO INTERNATIONAL | MTD | $46.0K | 36 | flat | 11q | HELD | |
| AGILENT TECHNOLOGIES INC | A | $43.8K | 330 | flat | 11q | -50.3%-$44.4K | |
| QUALCOMM INC | QCOM | $36.4K | 197 | flat | 11q | HELD | |
| ZOETIS INC | ZTS | $28.0K | 390 | flat | 14q | -26.8%-$10.3K | |
| ORACLE CORP | ORCL | $28.0K | 191 | flat | 11q | HELD | |
| QUEST DIAGNOSTICS INC | DGX | $27.8K | 131 | flat | 5q | HELD | |
| RECURSION PHARMACEUTICALS IN | RXRX | $17.0K | 4,627 | flat | 12q | HELD |
By sector
Industry comes from the SIC code on each company's own SEC filings, which is self-reported and sometimes out of date. Derivative exposure is counted with the shares. Securities the SEC assigns no industry - funds, trusts, foreign issues - are shown as not classified rather than dropped.
| Sector | Value | Share |
|---|---|---|
| Biotech & Pharma | $3.6B | 75.1% |
| Medical Devices | $645.8M | 13.6% |
| Insurance | $146.4M | 3.1% |
| Other sectors | $150.2M | 3.2% |
| Not classified | $240.7M | 5.1% |
Quarter by quarter
| Quarter | Value | Positions | New | Added | Trimmed | Exited | Top 10 | Days to file |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | $4.8B | 148 | 17 | 39 | 64 | 24 | 42.9% | 45 |
| Q1 2026 | $4.2B | 155 | 19 | 33 | 83 | 40 | 41.9% | 45 |
| Q4 2025 | $5.3B | 176 | 37 | 46 | 79 | 9 | 49.5% | 48 |
| Q3 2025 | $4.8B | 148 | 17 | 39 | 75 | 11 | 49.9% | 45 |
| Q2 2025 | $4.5B | 142 | 7 | 38 | 57 | 13 | 49.8% | 45 |
| Q1 2025 | $4.5B | 148 | 10 | 26 | 72 | 23 | 48.6% | 44 |
| Q4 2024 | $5.2B | 161 | 13 | 42 | 64 | 15 | 44.1% | 45 |
| Q3 2024 | $6.2B | 163 | 12 | 54 | 65 | 15 | 39.2% | 45 |
| Q2 2024 | $6.2B | 166 | 10 | 59 | 53 | 13 | 40.0% | 45 |
| Q1 2024 | $6.6B | 169 | 23 | 60 | 70 | 15 | 37.2% | 45 |
| Q4 2023 | $6.5B | 161 | 25 | 27 | 77 | 18 | 39.8% | 45 |
| Q3 2023 | $6.2B | 154 | 11 | 35 | 66 | 13 | 40.6% | 45 |
| Q2 2023 | $7.0B | 156 | 9 | 51 | 46 | 12 | 36.6% | 45 |
| Q1 2023 | $6.9B | 159 | 7 | 39 | 62 | 19 | 36.5% | 45 |
| Q4 2022 | $7.5B | 171 | 8 | 65 | 46 | 13 | 36.1% | 45 |
| Q3 2022 | $7.0B | 176 | 15 | 37 | 75 | 11 | 34.8% | 45 |
| Q2 2022 | $7.1B | 172 | 10 | 56 | 79 | 15 | 34.7% | 42 |
| Q1 2022 | $8.6B | 177 | 16 | 48 | 73 | 30 | 30.8% | 43 |
| Q4 2021 | $9.7B | 191 | 14 | 58 | 54 | 42 | 29.7% | 41 |
| Q3 2021 | $9.9B | 219 | 12 | 54 | 50 | 7 | 29.9% | 43 |
| Q2 2021 | $10.2B | 214 | 12 | 78 | 41 | 14 | 30.3% | 43 |
| Q1 2021 | $9.5B | 216 | 15 | 96 | 75 | 21 | 29.1% | 42 |
| Q4 2020 | $8.7B | 222 | 18 | 81 | 64 | 13 | 31.9% | 47 |
| Q3 2020 | $7.2B | 217 | 20 | 70 | 37 | 11 | 34.8% | 47 |
| Q2 2020 | $7.1B | 208 | 17 | 83 | 49 | 23 | 40.2% | 44 |
| Q1 2020 | $5.2B | 214 | 16 | 78 | 50 | 17 | 40.7% | 44 |
| Q4 2019 | $6.3B | 215 | 22 | 85 | 42 | 17 | 41.2% | 45 |
| Q3 2019 | $5.4B | 210 | 22 | 130 | 35 | 13 | 41.7% | 45 |
| Q2 2019 | $5.9B | 201 | 84 | 85 | 22 | 19 | 42.4% | 45 |
| Q1 2019 | $1.8B | 136 | 17 | 79 | 29 | 19 | 36.8% | 45 |
| Q4 2018 | $1.5B | 138 | 0 | 0 | 0 | 0 | 38.6% | 43 |
Rows marked UNVERIFIED ID, PLACEHOLDER ID, TICKER AS ID or NON-CUSIP ID carry an identifier that is not a valid CUSIP. They are shown because the filer reported that money, but treat the security named with caution - hover the chip for what is wrong with it, and see the methodology.
Held counts consecutive filings in which this manager reported the position, and can reach further back than the quarters listed above: the tabs begin at Q4 2018 because earlier coverage is too sparse to describe a market, but tenure is counted over every filing we hold, some reaching to 2007. A position sold and later rebought starts again from one.
Weight change is the shift in this position's share of the whole book, in percentage points. It is the more useful column: when money flows into or out of a broad fund, almost every holding is bought or sold at once, so added and trimmed largely track flows. A weight that rose while the book shrank is a decision. Both compare with the previous quarter this filer reported, not the previous calendar quarter.